Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study.

Autor: Kado J; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.; Medical School, University of Western Australia, Perth, Western Australia, Australia., Salman S; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.; Medical School, University of Western Australia, Perth, Western Australia, Australia.; Clinical Pharmacology and Toxicology Unit, PathWest, Western Australia, Australia., Hla TK; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.; Medical School, University of Western Australia, Perth, Western Australia, Australia.; Department of Infectious Diseases, Fiona Stanley Hospital, Perth, Western Australia, Australia., Enkel S; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.; Medical School, University of Western Australia, Perth, Western Australia, Australia., Henderson R; Medical Imaging Department, Perth Children's Hospital, Nedlands, Western Australia, Australia., Hand RM; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.; Department of Infectious Diseases, Royal Perth Hospital, Perth, Western Australia, Australia., Hort A; Western Australian Country Health Service, Perth, Western Australia, Australia., Page-Sharp M; Curtin Medical School, Curtin University, Bentley, Western Australia, Australia., Batty K; Curtin Medical School, Curtin University, Bentley, Western Australia, Australia., Moore BR; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.; Medical School, University of Western Australia, Perth, Western Australia, Australia.; Curtin Medical School, Curtin University, Bentley, Western Australia, Australia., Bennett J; Department of Public Health, University of Otago, Wellington, New Zealand., Anderson A; Te Kupenga Hauora Maori, University of Auckland, Auckland, New Zealand., Carapetis J; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.; Medical School, University of Western Australia, Perth, Western Australia, Australia.; Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia., Manning L; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.; Medical School, University of Western Australia, Perth, Western Australia, Australia.; Department of Infectious Diseases, Fiona Stanley Hospital, Perth, Western Australia, Australia.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2023 Dec 14; Vol. 67 (12), pp. e0096223. Date of Electronic Publication: 2023 Nov 16.

A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies.

Autor: Hand RM; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia., Salman S; Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia., Newall N; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia., Vine J; Department of Ambulatory Care, Perth Children's Hospital, Perth, Western Australia, Australia., Page-Sharp M; School of Pharmacy and Biomedical Sciences, Curtin University, Bentley, Western Australia, Australia., Bowen AC; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.; Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.; Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia., Gray K; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia., Baker A; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia., Kado J; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia., Joseph J; PathWest Laboratories, Nedlands, Perth, Western Australia, Australia., Marsh J; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia., Ramsay J; Department of Cardiology, Perth Children's Hospital, Perth, Western Australia, Australia., Sika-Paotonu D; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.; Dean's Department and Department of Pathology & Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.; Faculty of Health, Victoria University of Wellington, Wellington, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand., Batty KT; School of Pharmacy and Biomedical Sciences, Curtin University, Bentley, Western Australia, Australia., Manning L; Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia., Carapetis J; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.; Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.; Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Jul 01; Vol. 74 (7), pp. 1984-1991.

Efficacy of light-protective additive packaging in protecting milk freshness in a retail dairy case with LED lighting at different light intensities.

Autor: Wang A; Department of Food Science and Technology, Virginia Polytechnic Institute and State University (Virginia Tech), Blacksburg 24061, United States. Electronic address: waili9@vt.edu., Dadmun CH; Department of Chemistry, College of Charleston, Charleston 29424, United States., Hand RM; Department of Food Science and Human Nutrition, Michigan State University, East Lansing 48824, United States., O'Keefe SF; Department of Food Science and Technology, Virginia Polytechnic Institute and State University (Virginia Tech), Blacksburg 24061, United States., Phillips JB; Department of Food Science and Technology, Virginia Polytechnic Institute and State University (Virginia Tech), Blacksburg 24061, United States., Anders KA; Department of Food Science and Technology, Virginia Polytechnic Institute and State University (Virginia Tech), Blacksburg 24061, United States., Duncan SE; Department of Food Science and Technology, Virginia Polytechnic Institute and State University (Virginia Tech), Blacksburg 24061, United States.

Publikováno v: Food research international (Ottawa, Ont.) [Food Res Int] 2018 Dec; Vol. 114, pp. 1-9. Date of Electronic Publication: 2018 Jul 31.